Multiple Sclerosis Performance Test: validation of self-administered neuroperformance modules.

BACKGROUND AND PURPOSE: The purpose was to determine the test-retest reliability, practice effects, convergent validity and sensitivity to multiple sclerosis (MS) disability of neuroperformance subtests from the patient self-administered Multiple Sclerosis Performance Test (MSPT) designed to assess low contrast vision (Contrast Sensitivity Test, CST), upper extremity motor function (Manual Dexterity Test, MDT) and lower extremity motor function (Walking Speed Test, WST) and to introduce the concept of regression-based norms to aid clinical interpretation of performance scores using the MSPT cognition test (Processing Speed Test, PST) as an example. METHODS: Substudy 1 assessed test-retest reliability, practice effects and convergent validity of the CST, MDT and WST in 30 MS patients and 30 healthy controls. Substudy 2 examined sensitivity to MS disability in over 600 MS patients as part of their routine clinic assessment. Substudy 3 compared performance on the PST in research volunteers and clinical samples. RESULTS: The CST, MDT and WST were shown to be reliable, valid and sensitive to MS outcomes. Performance was comparable to technician-administered testing. PST performance was poorer in the clinical sample compared with the research volunteer sample. CONCLUSIONS: The self-administered MSPT neuroperformance modules produce reliable, objective metrics that can be used in clinical practice and support outcomes research. Published studies which require patient voluntary consent may underestimate the rate of cognitive dysfunction observed in a clinical setting.

Immunohistochemical evidence of cytochrome C oxidase subunit II involvement in pulmonary hypertension syndrome (PHS) in broilers.

Defects and variation in the relative amount of protein subunits in the mitochondrial electron transport chain (ETC) have been hypothesized to be involved, in part, in the pathogenesis of pulmonary hypertension syndrome (PHS), a costly metabolic disease. Thus, the major objective of this study was to determine whether differences in relative amounts of cytochrome c oxidase subunit I and II (COX I and II) can be detected by immunohistochemistry and digital image analysis in muscle tissue of broilers with PHS compared to control broilers. Cross sections of the breast muscle (pectoralis major) were stained with monoclonal antibodies for COX I and II. Relative areas of multiple microscope viewing fields (400x) per tissue section of COX I and II were quantified by counting immunopositive pixels on the digital images. Whereas the number of immunopositive pixels for COX II was higher in PHS birds compared to controls, there were no difference for COX I. The amount of COX II was positively correlated with the right to total ventricular weight ratio (RV:TV), suggesting that there may be increased expression of COX II associated with severity of pulmonary arterial hypertension. Thus, it is possible that COX II expression in PHS broiler may be involved in the pathogenesis of PHS.